摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-甲基-2-萘甲酸甲酯 | 150256-07-8

中文名称
5-甲基-2-萘甲酸甲酯
中文别名
——
英文名称
5-methyl-2-naphthoic acid methyl ester
英文别名
Methyl 5-methyl-2-naphthoate;methyl 5-methylnaphthalene-2-carboxylate
5-甲基-2-萘甲酸甲酯化学式
CAS
150256-07-8
化学式
C13H12O2
mdl
——
分子量
200.237
InChiKey
QKENNVNRWMEWOX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-甲基-2-萘甲酸甲酯乙醇 、 sodium hydroxide 作用下, 反应 5.0h, 生成 5-methyl-2-naphthoic acid
    参考文献:
    名称:
    一系列有力和选择性的线性速激肽NK2受体拮抗剂对C和N末端部分的调节
    摘要:
    本文中,我们描述了一系列新的有效速激肽NK的合成2通过ibodutant的C-和N-末端部分的调制(MEN 15596,受体拮抗剂1)。N末端的苯并[ b ]噻吩环被不同的取代萘和苯并呋喃取代,同时在C末端的四氢吡喃部分评估了进一步的修饰。大多数化合物表现出对人NK 2受体的高亲和力和体外拮抗剂的高效力,表明可以在分子的两个末端引入广泛的取代基,而不会影响与NK 2受体的相互作用。对选定的化合物进行了体内测试,证实了其作为NK的活性2个拮抗剂。特别是,对豚鼠静脉内和静脉内给药后,化合物61b能够拮抗NK 2诱导的结肠收缩,其作用力和作用持续时间与参考化合物1(MEN 15596,ibodutant)完全相同。
    DOI:
    10.1002/cmdc.200900389
  • 作为产物:
    描述:
    硝基甲烷 、 在 caesium carbonate 作用下, 以 二甲基亚砜 为溶剂, 反应 10.0h, 生成 5-甲基-2-萘甲酸甲酯
    参考文献:
    名称:
    一系列有力和选择性的线性速激肽NK2受体拮抗剂对C和N末端部分的调节
    摘要:
    本文中,我们描述了一系列新的有效速激肽NK的合成2通过ibodutant的C-和N-末端部分的调制(MEN 15596,受体拮抗剂1)。N末端的苯并[ b ]噻吩环被不同的取代萘和苯并呋喃取代,同时在C末端的四氢吡喃部分评估了进一步的修饰。大多数化合物表现出对人NK 2受体的高亲和力和体外拮抗剂的高效力,表明可以在分子的两个末端引入广泛的取代基,而不会影响与NK 2受体的相互作用。对选定的化合物进行了体内测试,证实了其作为NK的活性2个拮抗剂。特别是,对豚鼠静脉内和静脉内给药后,化合物61b能够拮抗NK 2诱导的结肠收缩,其作用力和作用持续时间与参考化合物1(MEN 15596,ibodutant)完全相同。
    DOI:
    10.1002/cmdc.200900389
点击查看最新优质反应信息

文献信息

  • [EN] AMIDE DERIVATIVES AS SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS<br/>[FR] DERIVES D'AMIDE EN TANT QU'INHIBITEURS SELECTIFS DU RECAPTAGE DE LA SEROTONINE
    申请人:PFIZER LTD
    公开号:WO2004111003A1
    公开(公告)日:2004-12-23
    The present invention relates to compounds of formula (I), wherein R1 is selected from: (a) (C1-C6)alkyl, optionally substituted by 1-3 substituents, each independently selected from: (i) CF3, OH, (C1-C6)alkyl, (C3-C6)cycloalkyl, (C1-C6)alkoxy and halo; (ii) Phenyl, optionally fused with phenyl or cyclohexyl, said phenyl or fused phenyl optionally substituted with 1-3 groups selected from (C1-C6)alkyl, (C1-C6)alkyl ester, OH and halo; and (b) (C3-C6)cycloalkyl, optionally fused with (C5-C7)cycloalkyl, said cycloalkyl or fused cycloalkyl optionally substituted by OH, (C1-C6)alkyl, (C1-C6)alkoxy and halo. R2 is Phenyl, optionally fused to (C4-C6)cycloalkyl, phenyl or pyridyl, said phenyl or fused phenyl moiety optionally substituted with 1-3 groups each independently selected from (C1-C6)alkyl, (C1-C6)alkoxy, halo and OH. n is 1 to 2 and pharmaceutically acceptable salts, solvates or polymorphs thereof; With the proviso that when n is 2 and R1 is 2-(3,4-dimethoxylphenyl)-1-ethyl, 3,3­diphemyl-1-propyl or 2,4-difluorophenyl, then R2 cannot be 4-trifluoromethoxyphenyl, 2,4,6-trimethoxyphenyl, 4-acetoxyphenyl or 2,4-difluorophenyl; which are a class of selective serotonin re-uptake inhibitors (SSRIs).
    本发明涉及式(I)的化合物,其中R1从以下选项中选择:(a) (C1-C6)烷基,可选地被1-3个取代基取代,每个取代基独立地从以下选项中选择:(i) CF3,OH,(C1-C6)烷基,(C3-C6)环烷基,(C1-C6)烷氧基和卤素;(ii) 苯基,可选地与苯基或环己基融合,所述苯基或融合苯基可选地被1-3个取代基取代,所述取代基独立地从(C1-C6)烷基,(C1-C6)烷基酯,OH和卤素中选择;和(b) (C3-C6)环烷基,可选地与(C5-C7)环烷基融合,所述环烷基或融合环烷基可选地被OH,(C1-C6)烷基,(C1-C6)烷氧基和卤素取代。R2为苯基,可选地融合到(C4-C6)环烷基,苯基或吡啶基,所述苯基或融合苯基基团可选地被1-3个取代基取代,每个取代基独立地从(C1-C6)烷基,(C1-C6)烷氧基,卤素和OH中选择。n为1至2,以及其药学上可接受的盐、溶剂化合物或多形体;但是当n为2且R1为2-(3,4-二甲氧基苯基)-1-乙基,3,3-二苯基-1-丙基或2,4-二氟苯基时,R2不能为4-三氟甲氧基苯基,2,4,6-三甲氧基苯基,4-乙酰氧基苯基或2,4-二氟苯基;这些是一类选择性5-羟色胺再摄取抑制剂(SSRIs)。
  • Amide derivatives as selective serotonin re-uptake inhibitors
    申请人:Andrews David Mark
    公开号:US20050014789A1
    公开(公告)日:2005-01-20
    The present invention relates to compounds of formula (I), wherein R 1 is selected from: (a) (C 1 -C 6 )alkyl, optionally substituted by 1-3 substituents, each independently selected from: (i) CF 3 , OH, (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, (C 1 -C 6 )alkoxy and halo. (ii) Phenyl, optionally fused with phenyl or cyclohexyl, said phenyl or fused phenyl optionally substituted with 1-3 groups selected from (C 1 -C 6 )alkyl, (C 1 -C 6 )alkyl ester, OH and halo; and (b) (C 3 -C 6 )cycloalkyl, optionally fused with (C 5 -C 7 )cycloalkyl, said cycloalkyl or fused cycloalkyl optionally substituted by OH, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy and halo. R 2 is Phenyl, optionally fused to (C 4 -C 6 )cycloalkyl, phenyl or pyridyl, said phenyl or fused phenyl moiety optionally substituted with 1-3 groups each independently selected from (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, halo and OH; n is 1 to 2; and pharmaceutically acceptable salts, solvates or polymorphs thereof; With the proviso that when n is 2 and R 1 is 2-(3,4-dimethoxylphenyl)-1-ethyl, 3,3-diphenyl-1-propyl or 2,4-difluorophenyl, then R 2 cannot be 4-trifluoromethoxyphenyl, 2,4,6-trimethoxyphenyl, 4-acetoxyphenyl or 2,4-difluorophenyl; which are a class of selective serotonin re-uptake inhibitors (SSRIs).
    本发明涉及式(I)的化合物,其中R1选自:(a)(C1-C6)烷基,可选地被1-3个取代基取代,每个取代基独立地选自:(i)CF3,OH,(C1-C6)烷基,(C3-C6)环烷基,(C1-C6)烷氧基和卤素;(ii)苯基,可选地与苯基或环己基融合,所述苯基或融合苯基可选地被1-3个选自(C1-C6)烷基,(C1-C6)烷酯,OH和卤素的基团取代;和(b)(C3-C6)环烷基,可选地与(C5-C7)环烷基融合,所述环烷基或融合环烷基可选地被OH,(C1-C6)烷基,(C1-C6)烷氧基和卤素取代。R2为苯基,可选地融合到(C4-C6)环烷基、苯基或吡啶基上,所述苯基或融合苯基基团可选地被1-3个独立选自(C1-C6)烷基,(C1-C6)烷氧基,卤素和OH的基团取代;n为1到2;以及其药学上可接受的盐、溶剂或多型性;但当n为2且R1为2-(3,4-二甲氧基苯基)-1-乙基、3,3-二苯基-1-丙基或2,4-二氟苯基时,则R2不能是4-三氟甲氧基苯基、2,4,6-三甲氧基苯基、4-乙酰氧基苯基或2,4-二氟苯基;这是一类选择性5-羟色胺再摄取抑制剂(SSRI)。
  • Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
    申请人:Arimilli N. Murty
    公开号:US20070010489A1
    公开(公告)日:2007-01-11
    Phosphonate substituted compounds with HIV protease inhibitory properties having use as therapeutics and for other industrial purposes are disclosed. The compositions inhibit 5 HIV protease activity and/or are useful therapeutically for the treatment of AIDS and other antiviral infections, as well as in assays for the detection of HIV protease.
    本发明揭示了具有HIV蛋白酶抑制剂性质的膦酸酯取代化合物,其具有作为治疗剂和其他工业用途的用途。该组合物抑制5型HIV蛋白酶活性和/或在治疗艾滋病和其他抗病毒感染方面具有治疗作用,以及在检测HIV蛋白酶方面的检测中有用。
  • AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL
    申请人:SUMITOMO CHEMICAL COMPANY, LIMITED
    公开号:US20150005348A1
    公开(公告)日:2015-01-01
    An amide compound represented by formula (I) has an excellent pest control effect. (In the formula, Y represents a 3-7 membered saturated heterocyclic ring which contains, as ring-forming components(s), one or more atoms or groups that are selected from the group consisting of an oxygen atom and —S(O) t —, the saturated heterocyclic ring may have one to three atoms or groups selected from group D and t represents 0 or the like; x represents a C 1 -C 8 chain hydrocarbon group having one group that is selected from group A; W represents —CR 8 — or the like; r represents 1 or the like; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 may be the same or different and each represents a hydrogen atom or the like; and n represents 1 or the like.)
    式(I)所代表的酰胺化合物具有出色的杀虫效果。(在该式中,Y代表一个含有3-7个饱和杂环环的结构,该结构中包含一个或多个从氧原子和-S(O)t-组成的原子或基团,饱和杂环环可能有一个到三个从D组成的原子或基团,t代表0或类似物;x代表一个C1-C8链烃基,其中有一个来自A组的基团;W代表-CR8-或类似物;r代表1或类似物;R1、R2、R3、R4、R5、R6、R7和R8可以相同也可以不同,每个代表一个氢原子或类似物;n代表1或类似物。)
  • METHOD FOR CONTROLLING ARTHROPOD PEST
    申请人:SUMITOMO CHEMICAL COMPANY, LIMITED
    公开号:US20150344466A1
    公开(公告)日:2015-12-03
    An amide compound represented by formula (I): [wherein A represents a 3- to 7-membered saturated heterocyclic ring which contains, as ring-forming component(s), one or more atoms or groups selected from the group consisting of an oxygen atom and —S(O) t —, t represents 0, etc., R 1 and R 2 are the same or different and represent a hydrogen atom, etc., n represents 0, etc., the following formula (II): represents a 5-membered aromatic ring, in which Z represents a nitrogen atom or a carbon atom and X 1 , X 2 and X 3 are the same or different and represent a nitrogen atom, etc., R 3 and R 4 are the same or different and represent a hydrogen atom, etc., m represents 0 to 2, Q represents one group selected from group A or a C1 to C8 chain hydrocarbon group optionally having one group selected from group A, Y represents an oxygen atom, etc., u represents 0, etc., and v represents 0, etc.] has excellent arthropod pest controlling effects.
    化合物式(I)所代表的酰胺化合物:[其中A代表一个3到7个成员的饱和杂环环,该环包含作为环构成组分之一或多个原子或基团,所选自氧原子和—S(O)t—群,t代表0等;R1和R2相同或不同,代表氢原子等;n代表0等;下列式子(II)代表一个5个成员的芳香环,在该环中Z代表一个氮原子或一个碳原子,X1、X2和X3相同或不同,代表氮原子等,R3和R4相同或不同,代表氢原子等,m代表0到2,Q代表从群A中选择的一个群或一个C1到C8链烃基团,该基团可以选择从群A中选择的一个群,Y代表氧原子等,u代表0等,v代表0等]具有优良的节肢动物害虫控制效果。
查看更多